英科医疗
(300677)
| 流通市值：252.59亿 | | | 总市值：355.20亿 |
| 流通股本：4.66亿 | | | 总股本：6.55亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 6,909,022,700.33 | 2,887,034,413.31 | 9,925,819,444.72 | 7,424,714,825.22 |
| 营业总成本 | 5,605,231,332.95 | 2,673,510,336.68 | 9,433,955,186.7 | 6,860,935,348.14 |
| 其他经营收益 | | | | |
| 营业利润 | 1,096,215,981.13 | 40,279,477.7 | 1,230,170,954.33 | 1,065,874,643.11 |
| 利润总额 | 1,072,178,844.56 | 46,347,982.77 | 1,229,740,144.61 | 1,060,491,500.14 |
| 净利润 | 904,303,773.55 | 10,590,948.83 | 1,047,187,466.95 | 951,613,047.38 |
| 每股收益 | | | | |
| 其他综合收益 | -58,658,081.63 | -15,695,249.67 | -41,766,121.34 | -26,053,239.39 |
| 综合收益总额 | 845,645,691.92 | -5,104,300.84 | 1,005,421,345.61 | 925,559,807.99 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 19,102,789,278.83 | 16,430,446,610.36 | 16,299,013,495.4 | 25,622,346,300.27 |
| 非流动资产: | | | | |
| 非流动资产合计 | 22,140,353,956.85 | 23,869,391,028.9 | 23,791,459,064.17 | 14,343,391,341.77 |
| 资产总计 | 41,243,143,235.68 | 40,299,837,639.26 | 40,090,472,559.57 | 39,965,737,642.04 |
| 流动负债: | | | | |
| 流动负债合计 | 19,466,108,506.41 | 19,480,949,569.23 | 19,178,160,692.87 | 19,076,420,717.76 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,390,245,311.78 | 2,249,453,163.98 | 2,340,416,363.62 | 2,422,040,968.88 |
| 负债合计 | 21,856,353,818.19 | 21,730,402,733.21 | 21,518,577,056.49 | 21,498,461,686.64 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 19,000,022,074.47 | 18,249,840,573.28 | 18,253,839,363.41 | 18,159,907,594.79 |
| 股东权益合计 | 19,386,789,417.49 | 18,569,434,906.05 | 18,571,895,503.08 | 18,467,275,955.4 |
| 负债和股东权益合计 | 41,243,143,235.68 | 40,299,837,639.26 | 40,090,472,559.57 | 39,965,737,642.04 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 7,571,522,108.49 | 3,188,475,970.44 | 10,901,873,759.28 | 8,480,089,809.6 |
| 经营活动现金流出小计 | 5,813,777,266.14 | 2,898,215,434.61 | 9,016,844,379.72 | 7,373,407,530.53 |
| 经营活动产生的现金流量净额 | 1,757,744,842.35 | 290,260,535.83 | 1,885,029,379.56 | 1,106,682,279.07 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,444,919,276.37 | 1,547,849,152.52 | 19,426,389,940.99 | 8,502,409,581.91 |
| 投资活动现金流出小计 | 11,321,514,851.38 | 1,878,510,934.91 | 30,878,069,946.93 | 13,157,931,482.22 |
| 投资活动产生的现金流量净额 | -2,876,595,575.01 | -330,661,782.39 | -11,451,680,005.94 | -4,655,521,900.31 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 18,001,119,942.35 | 6,046,813,358.23 | 31,517,157,894.05 | 21,770,941,341.51 |
| 筹资活动现金流出小计 | 14,830,524,813.53 | 5,163,475,090.44 | 23,139,439,988.51 | 16,392,725,649.84 |
| 筹资活动产生的现金流量净额 | 3,170,595,128.82 | 883,338,267.79 | 8,377,717,905.54 | 5,378,215,691.67 |
| 汇率变动对现金及现金等价物的影响 | -230,168,093.82 | -103,528,844.79 | -306,413,256.68 | -78,159,769.22 |
| 现金及现金等价物净增加额 | 1,821,576,302.34 | 739,408,176.44 | -1,495,345,977.52 | 1,751,216,301.21 |
| 期末现金及现金等价物余额 | 3,624,100,223.54 | 2,541,932,097.64 | 1,802,523,921.2 | 5,049,086,199.93 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 1,821,576,302.34 | - | -1,495,345,977.52 | - |
最新报告期：2026-08-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国信证券 | 凌珑,张超,彭思宇,陈曦炳 | 3.61 | 4.53 | 5.27 | 2026-08-31 |
| 东方证券 | 伍云飞 | 3.26 | 3.70 | 4.27 | 2026-08-27 |
| 浙商证券 | 史凡可,褚远熙 | 3.58 | 5.17 | 6.50 | 2026-08-26 |
| 开源证券 | 余汝意,石启正 | 3.19 | 4.71 | 5.80 | 2026-08-26 |
| 东北证券 | 陈渊文 | 3.86 | 3.92 | 4.97 | 2026-07-30 |